GEM
DEAD

Serial Number

97099073

Owner

Obsidio, Inc.

Attorney

Sara Citrowske

Filing Date

Oct 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GEM Trademark

Serial Number: 97099073

GEM is a trademark filed by Obsidio, Inc. on October 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Obsidio, Inc. (2 trademarks)

Unit 4-C
Columbia, SC 29201

Entity Type: 03

Trademark Details

Filing Date

October 29, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials, namely, hydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, hydrogels; preparations for implantable surgical materials, namely, hydrogels; preparations for implantable hydrogel-based embolics; embolization therapy preparations; medical preparations for embolization therapy systems; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; surgical hydrogel precursors; surgical hydrogel precursors for kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations

Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for embolization; medical device, namely, arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated liquid embolics; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical apparatus, namely, system for vascular embolization procedures; embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis, namely, embolization therapy system, featuring hydrogel precursors and applicator; kits for vascular embolization procedures, featuring hydrogel precursors and applicator

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 13, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 13, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 13, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 25, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 25, 2022 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 18, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 18, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2022 REAP
ASSIGNED TO EXAMINER
Aug 17, 2022 DOCK
ASSIGNED TO EXAMINER
Aug 9, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2021 NWOS
NEW APPLICATION ENTERED
Nov 2, 2021 NWAP